Transcription factor 7-like 2 (TCF7L2) gene polymorphism and complication/comorbidity profile in type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 93, Issue 3, 2011, Pages 390-395

  Buraczynska, Monika ^a   Swatowski, Andrzej ^a   Markowska Gosik, Dorota ^a   Kuczmaszewska, Agata ^a   Ksiazek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Diabetic nephropathy; Gene polymorphism; Risk alleles; TCF7L2; Type 2 diabetes

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL CLASSIFICATION; COMORBIDITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION FACTOR 7 LIKE 2 GENE;

ADULT; AGED; ALLELES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 80052714003     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.017     Document Type: Article

References (29)

1. O'Rahilly S., Barroso I., Wareham N.J. Genetic factors in type 2 diabetes: the end of the beginning?. Science 2005, 307:370-373.
2. Frayling T.M. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007, 8:657-662.
3. Brantjes H., Barker N., van Es J., Clevers H. Lady Justice casting the final verdict on the outcome of Wnt signaling. Biol Chem 2002, 383:255-261.
4. Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1338.
5. Duval A., Busson-Leconiat M., Berger R., Hamelin R. Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet 2000, 88:264-265.
6. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
7. Groves C.J., Zeggini E., Minton J., Frayling T.M., Weedon M.N., Rayner N.W., et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006, 55:2640-2644.
8. Humphries S.E., Gable D., Cooper J.A., Ireland H., Stephens J.W., Hurel S.J., et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites. Indian Asians and Afro-Caribbean men and women. J Mol Med 2006, 84:1-10.
9. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C., Sjögren M., et al. Common single nucleotide polymorphisms In TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895.
10. Zhang C., Qi L., Hunter D.J., Meigs J.B., Manson J.E., van Dam R.M., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of the U.S. women and men. Diabetes 2006, 55:2645-2648.
11. Chandak G.R., Janipalli C.S., Bhaskar S., Kulkarni S.R., Mohankrishna P., Hattersley A.T., et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. Diabetologia 2007, 50:63-67.
12. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Y., Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
13. Zeggini E., Weedon M.N., Lindgren C.M., Frayling T.M., Elliott K.S., Lango H., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
14. Tabara Y., Osawa H., Kawamoto R., Onuma H., Shimizu I., Miki T., et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 2009, 58:493-498.
15. Florez J.C., Jablonski K.A., Bayley N., Pollin T.I., de Bakker P.I., Shuldiner A.R., et al. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. New Engl J Med 2006, 355:241-250.
16. Mayans S., Lackovic K., Lindgren P., Ruikka K., Agren A., Eliasson M., et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet 2007, 15:342-346.
17. Thorsby P.M., Midthjell K., Gjerlaugsen N., Holmen J., Hanssen K.F., Birkeland K.I., et al. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study-the HUNT study. Scand J Clin Lab Invest 2009, 69:282-287.
18. Cauchi S., Meyre D., Choquet H., Dina C., Born C., Marre M., et al. Transcription factor TCF7L2 genetic study in a French general population: the data from an epidemiological study on the insulin resistance syndrome (DESIR) study. Diabetes 2006, 55:3189-3192.
19. Sladek R., Rocheleau G., Rung J., Dina C., Shen L., Serre D., et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885.
20. Palmer N.D., Hester J.M., An S.S., Adeyemo A., Rotimi C., Langefeld C.D., et al. Resequencing and analysis of variation in the TCF7L2 gene in African Americans suggests that SNP rs7903146 is the causal diabetes susceptibility variant. Diabetes 2011, 60:662-668.
21. Gaulton K.J., Nammo T., Pasquali L., Simon J.M., Giresi P.G., Fogarty M.P., et al. A map of open chromatin in human pancreatic islets. Nat Genet 2010, 42:255-259.
22. Melzer D., Murray A., Hurst A.J., Weedon M.N., Bandinelli S., Corsi A.M., et al. Effects of the diabetes linked TCF7L2 polymorphism in a representative older population. BMC Med 2006, 4:34-38.
23. Sale M.M., Smith S.G., Mychaleckyj J.C., Keene K.L., Langefeld C.D., Leak T.S., et al. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. Diabetes 2007, 56:2638-2642.
24. Wu L.S., Hsieh C.H., Pei D., Hung Y.J., Kuo S.W., Lin E. Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPARγ and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes. Nephrol Dial Transplant 2009, 24:3360-3366.
25. Bielinski S.J., Pankow J.S., Folsom A.R., North K.E., Boerwinkle E. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2008, 51:968-970.
26. Sousa A.G., Marquezine G.F., Lemos P.A., Martinez E., Lopes N., Hueb W.A., et al. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PLoS One 2009, 4(11).
27. Lehman D.M., Hunt K.J., Leach R.J., Hamlington J., Arya R., Abboud H.E., et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 2007, 56:389-393.
28. Kimber C.H., Doney A.S., Pearson E.R., McCarthy M.I., Hattersley A.T., Leese G.P., et al. TCF7L2 in the Go-DARTS study: evidence for a gene dosage effect on both diabetes susceptibility and control of glucose levels. Diabetologia 2007, 50:1186-1191.
29. Moczulski D., Gawlik B., August R., Strojek K., Grzeszczak W. TCF7L2 gene is associated with type 2 diabetes in Polish population. Diabetol Dosw Klin 2007, 7:109-111.